Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Evgen Pharma Plc LSE:EVG London Ordinary Share GB00BSVYN304 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.15 -1.97% 7.45 7.20 7.70 7.60 7.45 7.60 154,860 12:32:54
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -3.2 -2.1 - 20

Evgen Pharma Share Discussion Threads

Showing 7976 to 7999 of 8400 messages
Chat Pages: Latest  324  323  322  321  320  319  318  317  316  315  314  313  Older
DateSubjectAuthorDiscuss
01/4/2021
17:35
htTp://www.koreabiomed.com/news/articleView.html?idxno=10835 Someone have a word with James and get the garlic & ginger out :)
bumpa33
31/3/2021
20:15
Some chunky late reported trades as usual, certainly suggests shares are being accumulated on the cheap.....Q2 fast approaching, plenty of action anticipated. Gla :-)
moneymunch
30/3/2021
21:36
Nico must have a mate with a rubber.
bocker01
30/3/2021
21:14
Haha That's not me bockerI'm certainly not bearish at this price I just think directors should've bought more stockIt's a buy at this EV ,just not a conviction buy
nico115
30/3/2021
21:04
Lol, yep a deletion, now why does that happen???
moneymunch
30/3/2021
20:09
Oops there two of them. Thumb must have got in the way
bocker01
30/3/2021
20:07
2m buy? You’d have done some research before lashing that out on a small AIM stock. Unless you’re called Fat Fingers Nico.
bocker01
30/3/2021
15:12
Just noticed the 2m buy...all bodes well, including today's weather....Scorchio😎😎28526;👍
moneymunch
30/3/2021
12:22
Hopefully so clocktower, there's lots of news that could land at anytime but at the moment it looks like the market is awaiting Prof Chalmers SFX-01's preliminary efficacy data for Covid/Ards, which near term could have a dramatic effect on proceedings ( either way ), news of which could be very close imho and Huw might want this out of the way before he updates the market on the rest of the pipeline, to cover all eventualities.....Gl ;-)
moneymunch
30/3/2021
11:09
Not the best of buys at 8p it turns out but hey ho things can change quickly and turn around in next to no time.
clocktower
29/3/2021
18:48
Let the trend be your friend - I suspect if one ignores ones's friend in this case your might be on a diet of bread and water sooner than one of steak and chips.
pugugly
29/3/2021
17:25
Closed at multi year lows
nico115
29/3/2021
09:49
Watch STX go A far better bet Huge director buying
nico115
28/3/2021
22:14
Sorry amaretto Huge warning sign when BOD raises 10m and puts in 300 quidMajor red sign Sorry but they aren't confident why should we be ??
nico115
28/3/2021
21:20
Sell or not to sellUndecided
nico115
28/3/2021
20:52
We could offer Pets at Home a licence agreement for it... :)
lovewinshatelosses
28/3/2021
20:23
Forget rabbits, don’t bother with humans, Let’s go for the REAL money market (veterinary) and... DOGS!?! httPs://vcahospitals.com/know-your-pet/acute-respiratory-distress-syndrome-shock-lung-in-dogs
bumpa33
28/3/2021
18:25
If SFX-01 works as well on humans, as SFN dosing appears to work on rabbits, then it will be a mint. Gl :-) Sulforaphane significantly inhibits ARDS in rabbits and plays a protective role in ARDS through upregulating Nrf2. hTtps://www.researchgate.net/publication/324237365_Protective_mechanism_of_sulforaphane_in_Nrf2_and_anti-lung_injury_in_ARDS_rabbits
moneymunch
28/3/2021
17:21
I was just musing on the idea of the Covid trial being maybe almost a shot to nothing for Octopus et al (hence the fairly substantial discount, because the other pipeline opportunities will not yield imminent results) - but you might be right and perhaps this is a little too left field. Yes, but not only 4D, also SNG, each time soon after another encouraging RNS dropped. I was not the only holder there at the time thinking 'this guy must know something that we do not, or why would he be selling down now'?! I was therefore more relaxed when he started doing it with 4D, having seen that it was a strategy, not inside knowledge of impending doom. I am gradually starting to see such selling down as an opportunity now, in certain circumstances like the above. I was less overweight in both those cases than I am here though, so need to be more cautious here until we see something to validate current faith. I went against my original plan in taking up my OO shares, plus another 10K on top, when the inside buying was so weak, but whether it will make me a mug or make me a mint, we shall see :)
lovewinshatelosses
28/3/2021
15:48
As for Griffiths, wasn’t it him weighing down on 4D Pharma sp, for ages - before it shot north?
bumpa33
28/3/2021
15:38
Lwhl - I can’t see ii’s stumping up £11m if they think the imminent first batch of efficacy data is going to disappoint? If you wanted in you’d wait until AFTER release? No guarantees of course, it has happened before in others. Appears to me that Huw seems to stress the ARDS aspect of the trial, over Covid.
bumpa33
28/3/2021
15:01
My thinking currently is that neither the BOD, nor the new iis, are particularly confident in the Covid trial; IMO the real appetite resides in the breast cancer and glioma opportunities. If I am correct, it may also explain why RG has been selling down/out, as he does not seem to be one for hanging around to see results - and as some have suggested, if the covid trial is unsuccessful, it seems likely that the share price will drop significantly in the initial panic. At that point, RG and others may return here (as I remember happened last time this tanked on a bad trial result). The lack of inside buying and share price movement since the raise would seem to validate this bearish theory - but I am willing to take the risk of holding again now as I did back then, because a negative result is not a nailed on certainty, but a big share price rise would be in the event of good news, AIMO obviously. Nico - lets hope you are right about STX, but that big inside buying does not get them off the hook for the share price destruction and simple inability to get the product sold in the US which sees most (fellow) holders sitting on fairly significant paper losses right now! Compare and contrast with DNL to date, seeing as we are going off-piste somewhat... Anyway, lets hope EVGEN puts them both in the shade in time! GLA.
lovewinshatelosses
28/3/2021
14:34
As much as I am critical of Finncap, they have at least got some pretty significant names onto the share register. You would think the churn (at ii level) that i mentioned earlier, which started/coincided with the departure of Franklin, is a case of out with the old/in with the new and probably mirrors the overhaul in business model. It feels like it’s taken forever to get here but in reality 12 months to overhaul the board, business plan and the share register to the extent they have is not that long. I’ve said this many a time, the company has little value attributed to its lead compound - let’s see if they can start to change the markets mind. If they can, the rewards are obvious.
bumpa33
28/3/2021
12:46
Thx for the video Bumpa Do you believe a word he says ? You believe he's confident ? Remind me how many shares he has bought in the company ? Seriously ,shambolic
nico115
Chat Pages: Latest  324  323  322  321  320  319  318  317  316  315  314  313  Older
ADVFN Advertorial
Your Recent History
LSE
EVG
Evgen Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210515 15:16:20